ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+20.38%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$371M
AUM Growth
+$126M
(+51%)
Cap. Flow
+$91.8M
Cap. Flow
% of AUM
24.75%
Top 10 Holdings %
Top 10 Hldgs %
75.81%
Holding
77
New
9
Increased
15
Reduced
7
Closed
9
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$71.8M |
| 2 |
Indaptus Therapeutics
INDP
|
$20.8M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$11.2M |
| 4 |
Amicus Therapeutics
FOLD
|
$4.52M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$4.34M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$15.4M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
$7.78M |
| 3 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$4.47M |
| 4 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$4.41M |
| 5 |
AnaptysBio
ANAB
|
$3.97M |
Sector Composition
| 1 | Healthcare | 70.42% |
| 2 | Communication Services | 0% |
| 3 | Technology | 0% |